288 related articles for article (PubMed ID: 29409921)
1. A Rationally Designed Multifunctional Antibiotic for the Treatment of Drug-Resistant Acne.
Ghosh S; Sinha M; Bhattacharyya A; Sadhasivam S; Megha J; Reddy S; Saini S; Singh H; Kumar D; Kaur SP; Mishra M; Usharani D; Ghosh S; Sengupta S
J Invest Dermatol; 2018 Jun; 138(6):1400-1408. PubMed ID: 29409921
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of VB-1953 Topical Gel in Non-Responder Acne Patients with Clindamycin-Resistant Cutibacterium acnes.
Batra R; Sadhasivam S; Saini S; Gupta S; Bisen RKS; Sinha M; Ghosh S; Jain S
Drugs R D; 2020 Jun; 20(2):95-104. PubMed ID: 32222937
[TBL] [Abstract][Full Text] [Related]
3. The antimicrobial effect of CEN1HC-Br against Propionibacterium acnes and its therapeutic and anti-inflammatory effects on acne vulgaris.
Han R; Blencke HM; Cheng H; Li C
Peptides; 2018 Jan; 99():36-43. PubMed ID: 29108811
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic effect of tanshinone IIA on Propionibacterium acnes-induced inflammation in vitro.
Li Y; Zhou Y
Dermatol Ther; 2018 Nov; 31(6):e12716. PubMed ID: 30246913
[TBL] [Abstract][Full Text] [Related]
5. Propionibacterium acnes and antimicrobial resistance in acne.
Dessinioti C; Katsambas A
Clin Dermatol; 2017; 35(2):163-167. PubMed ID: 28274353
[TBL] [Abstract][Full Text] [Related]
6. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes.
Kuwahara K; Kitazawa T; Kitagaki H; Tsukamoto T; Kikuchi M
J Dermatol Sci; 2005 Apr; 38(1):47-55. PubMed ID: 15795123
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of two plant extracts against acne vulgaris: Initial results of microbiological tests and cell culture studies.
Kılıç S; Okullu SÖ; Kurt Ö; Sevinç H; Dündar C; Altınordu F; Türkoğlu M
J Cosmet Dermatol; 2019 Aug; 18(4):1061-1065. PubMed ID: 30414245
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic resistance in the topical treatment of acne vulgaris.
Leyden JJ
Cutis; 2004 Jun; 73(6 Suppl):6-10. PubMed ID: 15228128
[TBL] [Abstract][Full Text] [Related]
9. Suppression of Propionibacterium acnes Infection and the Associated Inflammatory Response by the Antimicrobial Peptide P5 in Mice.
Ryu S; Han HM; Song PI; Armstrong CA; Park Y
PLoS One; 2015; 10(7):e0132619. PubMed ID: 26197393
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity and antibiotic resistance in Propionibacterium acnes isolates and its therapeutic implications: blurring the lines between commensal and pathogenic phylotypes.
Sadhasivam S; Sinha M; Saini S; Kaur SP; Gupta T; Sengupta S; Ghosh S; Sardana K
Dermatol Ther; 2016 Nov; 29(6):451-454. PubMed ID: 27424878
[TBL] [Abstract][Full Text] [Related]
11. Treating acne with antibiotic-resistant bacterial colonization.
Tzellos T; Zampeli V; Makrantonaki E; Zouboulis CC
Expert Opin Pharmacother; 2011 Jun; 12(8):1233-47. PubMed ID: 21355786
[TBL] [Abstract][Full Text] [Related]
12. Acne and Propionibacterium acnes.
Bojar RA; Holland KT
Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
[TBL] [Abstract][Full Text] [Related]
13. Topical acne treatments in Europe and the issue of antimicrobial resistance.
Leccia MT; Auffret N; Poli F; Claudel JP; Corvec S; Dreno B
J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1485-92. PubMed ID: 25677763
[TBL] [Abstract][Full Text] [Related]
14. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance.
Leyden JJ; Del Rosso JQ; Webster GF
Cutis; 2007 Jun; 79(6 Suppl):9-25. PubMed ID: 17649854
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial and anti-inflammatory activities of endophytic fungi Talaromyces wortmannii extracts against acne-inducing bacteria.
Pretsch A; Nagl M; Schwendinger K; Kreiseder B; Wiederstein M; Pretsch D; Genov M; Hollaus R; Zinssmeister D; Debbab A; Hundsberger H; Eger A; Proksch P; Wiesner C
PLoS One; 2014; 9(6):e97929. PubMed ID: 24887557
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
17. Long-term administration of oral macrolides for acne treatment increases macrolide-resistant Propionibacterium acnes.
Nakase K; Okamoto Y; Aoki S; Noguchi N
J Dermatol; 2018 Mar; 45(3):340-343. PubMed ID: 29235673
[TBL] [Abstract][Full Text] [Related]
18. Alpha- and gamma-mangostins exhibit anti-acne activities via multiple mechanisms.
Xu N; Deng W; He G; Gan X; Gao S; Chen Y; Gao Y; Xu K; Qi J; Lin H; Shen L; Li X; Hu Z
Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):415-422. PubMed ID: 30422030
[No Abstract] [Full Text] [Related]
19. SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skin.
Fernandéz JR; Rouzard K; Voronkov M; Feng X; Stock JB; Stock M; Gordon JS; Shroot B; Christensen MS; Pérez E
J Cosmet Dermatol; 2012 Dec; 11(4):272-8. PubMed ID: 23174050
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong.
Luk NM; Hui M; Lee HC; Fu LH; Liu ZH; Lam LY; Eastel M; Chan YK; Tang LS; Cheng TS; Siu FY; Ng SC; Lai YK; Ho KM
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
